Selection of endpoints in clinical studies of enzyme replacement therapy in lysosomal storage disorders - Commentary

dc.contributor.authorHopwood, J.
dc.date.issued2001
dc.identifier.citationJournal of Inherited Metabolic Disease, 2001; 24(SUPPL. 2):45-46
dc.identifier.doi10.1023/A:1012459521922
dc.identifier.issn0141-8955
dc.identifier.issn1573-2665
dc.identifier.urihttp://hdl.handle.net/2440/32945
dc.language.isoen
dc.publisherKluwer Academic Publ
dc.rights© 2001 SSIEM and Kluwer Academic Publishers
dc.source.urihttp://dx.doi.org/10.1023/a:1012459521922
dc.titleSelection of endpoints in clinical studies of enzyme replacement therapy in lysosomal storage disorders - Commentary
dc.typeJournal article
pubs.publication-statusPublished

Files